144 related articles for article (PubMed ID: 21960935)
1. Emerging Strategies in the Use of IBD-related Serologic Markers.
Dubinsky MC
Gastroenterol Hepatol (N Y); 2008 Aug; 4(8):557-9. PubMed ID: 21960935
[No Abstract] [Full Text] [Related]
2. The diagnostic accuracy of serologic markers in children with IBD: the West Virginia experience.
Elitsur Y; Lawrence Z; Tolaymat N
J Clin Gastroenterol; 2005 Sep; 39(8):670-3. PubMed ID: 16082274
[TBL] [Abstract][Full Text] [Related]
3. High Incidence of Serologic Markers of Inflammatory Bowel Disease in Asymptomatic Patients with Glycogen Storage Disease Type Ia.
Lawrence NT; Chengsupanimit T; Brown LM; Weinstein DA
JIMD Rep; 2015; 24():123-8. PubMed ID: 26093626
[TBL] [Abstract][Full Text] [Related]
4. Relevance of serologic studies in inflammatory bowel disease.
Vernier G; Sendid B; Poulain D; Colombel JF
Curr Gastroenterol Rep; 2004 Dec; 6(6):482-7. PubMed ID: 15527678
[TBL] [Abstract][Full Text] [Related]
5. Serologic markers in inflammatory bowel disease (IBD).
Nakamura RM; Barry M
MLO Med Lab Obs; 2001 Nov; 33(11):8-15; quiz 16-9. PubMed ID: 11721286
[TBL] [Abstract][Full Text] [Related]
6. The role of autoantibodies in inflammatory bowel disease.
Herszényi L; Tulassay Z
Dig Dis; 2012; 30(2):201-7. PubMed ID: 22722439
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic Modalities for Inflammatory Bowel Disease: Serologic Markers and Endoscopy.
Clark C; Turner J
Surg Clin North Am; 2015 Dec; 95(6):1123-41, v. PubMed ID: 26596918
[TBL] [Abstract][Full Text] [Related]
8. Serologic markers in inflammatory bowel disease: state of the art.
Sandborn WJ
Rev Gastroenterol Disord; 2004; 4(4):167-74. PubMed ID: 15580151
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of novel serological markers and autoantibodies in dogs with inflammatory bowel disease.
Estruch JJ; Barken D; Bennett N; Krawiec DK; Ogilvie GK; Powers BE; Polansky BJ; Sueda MT
J Vet Intern Med; 2020 May; 34(3):1177-1186. PubMed ID: 32282988
[TBL] [Abstract][Full Text] [Related]
10. [Relevance of serologic studies in inflammatory bowel diseases].
Papp M; Altorjay I; Lakatos PL
Orv Hetil; 2007 May; 148(19):887-96. PubMed ID: 17478404
[TBL] [Abstract][Full Text] [Related]
11. New serologic markers for inflammatory bowel disease diagnosis.
Dotan I
Dig Dis; 2010; 28(3):418-23. PubMed ID: 20926866
[TBL] [Abstract][Full Text] [Related]
12. Advances in clinical laboratory tests for inflammatory bowel disease.
Nakamura RM; Matsutani M; Barry M
Clin Chim Acta; 2003 Sep; 335(1-2):9-20. PubMed ID: 12927679
[TBL] [Abstract][Full Text] [Related]
13. Biological markers in inflammatory bowel disease: practical consideration for clinicians.
Mendoza JL; Abreu MT
Gastroenterol Clin Biol; 2009 Jun; 33 Suppl 3():S158-73. PubMed ID: 20117339
[TBL] [Abstract][Full Text] [Related]
14. Serological markers in inflammatory bowel disease: a review of their clinical utility.
Barahona-Garrido J; Sarti HM; Barahona-Garrido MK; Hernández-Calleros J; Coss-Adame E; Garcia-Saenz SM; Yamamoto-Furusho JK
Rev Gastroenterol Mex; 2009; 74(3):230-7. PubMed ID: 19858012
[TBL] [Abstract][Full Text] [Related]
15. Utility of serological markers in inflammatory bowel diseases: gadget or magic?
Papp M; Norman GL; Altorjay I; Lakatos PL
World J Gastroenterol; 2007 Apr; 13(14):2028-36. PubMed ID: 17465443
[TBL] [Abstract][Full Text] [Related]
16. Serologic markers: impact on early diagnosis and disease stratification in inflammatory bowel disease.
Arai R
Postgrad Med; 2010 Jul; 122(4):177-85. PubMed ID: 20675980
[TBL] [Abstract][Full Text] [Related]
17. Markers that differentiate early from late IBD.
Huang C; Kugathasan S
Dig Dis; 2012; 30(4):380-2. PubMed ID: 22796800
[TBL] [Abstract][Full Text] [Related]
18. [Biomarkers in the diagnosis and therapy of inflammatory bowel diseases].
Iijima H; Shinzaki S; Tsujii M; Takehara T
Nihon Rinsho; 2012 May; 70(5):869-73. PubMed ID: 22620015
[TBL] [Abstract][Full Text] [Related]
19. What is the role of serological markers in the diagnosis of IBD?
Dubinsky MC
Inflamm Bowel Dis; 2008 Oct; 14 Suppl 2():S185-6. PubMed ID: 18816787
[TBL] [Abstract][Full Text] [Related]
20. Current and future role of biomarkers in Crohn's disease risk assessment and treatment.
Tamboli CP; Doman DB; Patel A
Clin Exp Gastroenterol; 2011; 4():127-40. PubMed ID: 21753895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
